What are the outcomes and mortality rates of hypertrophic cardiomyopathy in children based on age of presentation?
In children with idiopathic HCM surviving past 1 year of age, the annual mortality rate is 1%, which is significantly lower than previously reported and comparable to adult populations.
In children, HCM is a diverse disorder with outcomes that depend largely on cause and age. Patients presenting before 1 year of age have the broadest spectrum of causes and the poorest outcome. In those children with idiopathic HCM who survive beyond age 1, however, survival is independent of age at diagnosis, with an annual mortality rate (1%) that is much lower than previously reported in children and is not different from has been found in population-based studies in adults.
Colan et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: